U.S. STOCKS ON THE MOVE-Micron, Boeing, Calliditas Therapeutics

Calliditas Therapeutics AB

21/12/2023 12:20

* 
      Eikon search string for individual stock moves:  STXBZ 
    

        * 
      The Day Ahead newsletter: https://refini.tv/3LI4BU7
    

        * 
      The Morning News Call newsletter: https://refini.tv/3dKUyB8
    

  
U.S. stock index futures rose on Thursday, recovering from a broad sell-off on
Wall Street in the prior session as investors clung on to hopes of borrowing
costs easing next year, while chipmaker Micron advanced after delivering an
upbeat forecast.  .N 
    
    At 7:06 ET, Dow e-minis  1YMc1  were up 0.40% at 37,593. S&P 500 e-minis
 ESc1  were up 0.43% at 4,770, while Nasdaq 100 e-minis  NQc1  were up 0.61% at
16,867.75.
 
 The top three NYSE percentage gainers premarket  .PRPG.NQ :
 ** Terran Orbital Corporation  LLAP.K , up 13.9%
 ** Allego NV  ALLG.K , up 11.9%
 ** Sos Limited Adr  SOS , up 10.3%
 
 The top three NYSE percentage losers premarket  .PRPL.NQ :
 ** Regis Corporation  RGS , down 59.5%
 ** Ameren Corporation   AEE , down 56%
 ** Enzo Biochem Inc  ENZ , down 7%
 
 The top three Nasdaq percentage gainers premarket  .PRPG.O :
 ** Infrared Cameras Holdings Inc  MSAI.O , up 137.0%
 ** Hookipa Pharma Inc  HOOK.O , up 108.8%
 ** Shengfeng Development Ltd  SFWL.O , up 43.3%
 
 The top three Nasdaq percentage losers premarket  .PRPL.O :
 ** Sarcos Technology And Robotics Corporation  STRC.O , down 43.6%
 ** Nogin Inc  NOGN.O , down 29.7%
 ** Upexi Inc  UPXI.O , down 25.4%
 
 
 ** BlackBerry Ltd  BB.N : down 4.4% premarket
 BUZZ - ADRs slide as Q4 revenue forecast falls below estimates  urn:newsml:reuters.com:*:nL4N3DG246 

 ** Micron Technology Inc  MU.O : up 6.0% premarket
 BUZZ - Jumps after results, forecast top expectations  urn:newsml:reuters.com:*:nL4N3DG22H 
    
 ** Boeing Co  BA.N : up 1.7% premarket
 BUZZ - Up on report China to approve first 787 delivery since April 2021
 urn:newsml:reuters.com:*:nL4N3DG2AQ 
    
     ** Calliditas Therapeutics AB  CALT.O : up 15.1% premarket
 BUZZ - Surges on US FDA's approval for kidney disease drug  urn:newsml:reuters.com:*:nL4N3DG2C7
    

 (Compiled by Rajarshi Roy and Sneha S K)
 ((Sneha.sk@thomsonreuters.com))